Board Meeting25 Sept 2026, 06:01 pm
Sun Pharma Trading Window Closed for Q2 FY27 Results
AI Summary
Sun Pharmaceutical Industries Ltd has announced the closure of its trading window for dealing in the company's shares. This closure will be effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The specific date for the Board Meeting to approve these financial results will be communicated separately. This measure is in accordance with the company's Code of Conduct for Prohibition of Insider Trading.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for Q2 FY27 financial results announcement.
- Window reopens 48 hours after results declaration.
- Adheres to insider trading prohibition code.
Price Impact
More from SUNPHARMA